Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
Authors
Keywords
Pancreatic Cancer, National Comprehensive Cancer Network, National Comprehensive Cancer Network, Resection Rate, Complete Pathologic Response
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 23, Issue 13, Pages 4352-4360
Publisher
Springer Nature
Online
2016-07-01
DOI
10.1245/s10434-016-5373-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Hospital Volume on Surgical Outcomes After Pancreaticoduodenectomy
- (2016) Tatsuo Hata et al. ANNALS OF SURGERY
- Current standards and new innovative approaches for treatment of pancreatic cancer
- (2016) Thierry Conroy et al. EUROPEAN JOURNAL OF CANCER
- Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
- (2015) Eric A. Mellon et al. ACTA ONCOLOGICA
- Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
- (2015) Cristina R. Ferrone et al. ANNALS OF SURGERY
- FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
- (2015) Eran Sadot et al. ANNALS OF SURGICAL ONCOLOGY
- Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort
- (2015) Daniel Pietrasz et al. ANNALS OF SURGICAL ONCOLOGY
- Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
- (2015) Amudhan Pugalenthi et al. JOURNAL OF SURGICAL ONCOLOGY
- FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer
- (2015) Fausto Petrelli et al. PANCREAS
- Improved Long-Term Outcomes After Resection of Pancreatic Adenocarcinoma: A Comparison Between Two Time Periods
- (2014) Pablo E. Serrano et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
- (2014) Marlo Blazer et al. ANNALS OF SURGICAL ONCOLOGY
- FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
- (2014) L. Marthey et al. ANNALS OF SURGICAL ONCOLOGY
- FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience
- (2014) Sing Yu Moorcraft et al. Clinical Colorectal Cancer
- Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
- (2014) Maximilian Bockhorn et al. SURGERY
- Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
- (2013) Brian A. Boone et al. JOURNAL OF SURGICAL ONCOLOGY
- FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience
- (2013) J. E. Faris et al. ONCOLOGIST
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
- (2012) Peter J Hosein et al. BMC CANCER
- FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
- (2012) Krishna S. Gunturu et al. MEDICAL ONCOLOGY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More